US 8569379
Use of rasagiline for the treatment of olfactory dysfunction
granted A61KA61K31/135A61P
Quick answer
US patent 8569379 (Use of rasagiline for the treatment of olfactory dysfunction) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/135, A61P, A61P11/02, A61P25/00